Scalper1 News
Biotechs keep coming back to the pole position, or near it. In Wednesday’s IBD, the group was No. 1 among 197 industry groups. The group has moved in and out of favor this year, taking the No. 1 spot in mid-January, then fading from grace in April only to retake a leadership role in late September. The group received some negative attention in mid-July when Federal Reserve chief Janet Yellen said valuations were “substantially stretched” for Scalper1 News
Scalper1 News